(Press-News.org)
Osaka, Japan – One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome. However, what about patients who developed nephrotic syndrome in adulthood? As this drug is not yet approved for use in adult-onset patients, researchers from Japan wanted to highlight the profound benefits that rituximab has in adult-onset patients with these challenging conditions.
Nephrotic syndrome is a kidney disorder that causes the body to excrete too much protein in the urine. This condition can lead to edema, weight gain, and an increased risk of infections. For adults with frequently relapsing nephrotic syndrome (FRNS) or steroid-dependent nephrotic syndrome (SDNS), management can be particularly challenging. As a result, the researchers at The University of Osaka hoped to provide future disease management options through their research.
The study, a randomized, double-blind clinical trial recently published in JAMA, revealed the effectiveness of rituximab for preventing relapses in adult-onset FRNS or SDNS. The study involved 66 adult patients treated with either rituximab or a placebo. The primary goal was to determine whether rituximab could help maintain remission and reduce the frequency of relapses.
“Rituximab is a monoclonal antibody that depletes B cells, which are key players in the immune system. However, they can sometimes become overactive in nephrotic syndrome, leading to challenging symptoms,” explains lead author, Yoshitaka Isaka. “Rituximab is already used to treat nephrotic syndrome in children, with good success, so we investigated whether these benefits are also seen in adult-onset patients.”
The results have sparked great excitement. At the 49-week follow-up, 87.4% of adult patients treated with rituximab remained relapse-free, compared with only 38.0% treated with placebo. This impressive rate difference implies that rituximab is highly effective for preventing relapses in adults with FRNS or SDNS.
Adding to this revolutionary observation, the researchers found that among the patients who relapsed while initially being treated with placebo, none relapsed after switching to rituximab, and the time spent being relapse-free was longer in those who had rituximab throughout (49.0 weeks vs. 30.8 weeks with placebo).
The efficacy of rituximab at reducing relapses also came at very little cost, demonstrating the drug’s impressive safety. Crucially, no severe drug-related side effects were seen with rituximab, and serious drug-related side effects occurred at similar rates in both groups (3.1% in the rituximab group and 2.9% in the placebo group). The study also highlighted the potential benefits of rituximab in reducing the need for corticosteroids, which are commonly used to manage nephrotic syndrome, but can have undesirable side effects.
“The findings of this study provide critical insights,” says second author Yusuke Sakaguchi. “By reducing the frequency of relapses, rituximab may help adult patients reduce their reliance on corticosteroids and improve their overall quality of life.”
Overall, this clinical trial provides pivotal evidence that rituximab may be a safe and effective treatment option for adults with FRNS or SDNS. By preventing relapses and reducing the need for corticosteroids, rituximab offers renewed hope for better management of this challenging condition in adults.
##
The article, “Rituximab for relapsing nephrotic syndrome in adults; A Randomized Clinical Trial,” will be published in JAMA at DOI: https://doi.org/10.1001/jama.2025.19316.
About The University of Osaka
The University of Osaka was founded in 1931 as one of the seven imperial universities of Japan and is now one of Japan's leading comprehensive universities with a broad disciplinary spectrum. This strength is coupled with a singular drive for innovation that extends throughout the scientific process, from fundamental research to the creation of applied technology with positive economic impacts. Its commitment to innovation has been recognized in Japan and around the world. Now, The University of Osaka is leveraging its role as a Designated National University Corporation selected by the Ministry of Education, Culture, Sports, Science and Technology to contribute to innovation for human welfare, sustainable development of society, and social transformation.
Website: https://resou.osaka-u.ac.jp/en
END
About The Study: The expanding use of unregulated psilocybin mushrooms, combined with high variability in composition and common co-use with other substances, raises urgent public health concerns. Existing clinical data are insufficient to guide harm reduction or policy. There is a pressing need to pivot from controlled efficacy trials to real-world research on psilocybin use, including public education, potency testing, and age-specific risk assessment.
Corresponding Author: To contact the corresponding author, Kent E. Hutchison, PhD, email kent.hutchison@cuanschutz.edu.
To access the ...
About The Study: In a cross-sectional, nationally representative survey of 522 parent-teen dyads, frequent parent-teen sexual health communication was associated with increased teen self-efficacy for sexual and reproductive health information and service seeking, but this depended on how comfortable and informed their parents felt. These findings suggest that parents must possess accurate information and comfort to discuss sexual health topics.
Corresponding Author: To contact the corresponding author, Hannah Javidi, PhD, email hjavidi@ncat.edu.
To ...
"We are one step closer to a greener and climate-friendlier food production."
That is the assessment from Kasper Røjkjær Andersen and Simona Radutoiu, both professors of molecular biology at Aarhus University.
The two researchers led a new study where they discovered an important key to understanding how we can reduce agriculture’s need for artificial fertilizer.
Plants need nitrogen to grow, a nutrient that most crops solely get from fertilizer. Only a few plants, such as peas, clover, and beans, can manage without it. They live in symbiosis ...
A new AI-assisted brain atlas that can help visualise the human brain in unprecedented detail has been developed by UCL researchers, in a major step forward for neuroscience and neuroimaging.
The human brain comprises hundreds of interconnected regions that drive our thoughts, emotions, and behaviours. Existing brain atlases can identify major structures in MRI scans – such as the hippocampus, which supports memory and learning – but their finer sub-regions remain hard to detect. These distinctions matter because sub-regions ...
The two main approaches for discovering disease genes reveal distinct aspects of biology, a new study shows. While both methods are widely used, the research found that they identify different genes, with major implications for drug development.
Publishing online Nov. 5 in Nature, the study revolves around the human genome, which contains thousands of genes that provide instructions for making proteins, as well as regulatory DNA that controls when genes turn on. The new investigation takes a genome-wide ...
NYU Langone Health researchers found that a type of cell death caused by a buildup of highly reactive molecules suppresses lung tumor growth.
The process, called ferroptosis, evolved to let the body signal for self-destruction of cells that are overly stressed for various reasons. This includes cancer cells, but they in turn evolved to have mechanisms that counter ferroptosis so they can continue their uncontrolled growth despite the stress it creates.
Published online November 5 in Nature, the new study showed that an experimental treatment blocked the action in cancer ...
UNIVERSITY PARK, Pa. — Despite lithium-ion (Li) batteries’ role as one of the most widely used forms of energy storage, they struggle to operate at full power in low temperatures and sometimes even explode at high temperatures. Researchers at Penn State, however, have proposed a design that could hold the key to effective and stable power storage in a variety of climates.
The research, which was published today (Nov. 5) in Joule, investigated a state-of-the-art Li battery design known as an all-climate battery (ACB). Previous design approaches ...
In a major step toward practical quantum computers, Princeton engineers have built a superconducting qubit that lasts three times longer than today’s best versions.
“The real challenge, the thing that stops us from having useful quantum computers today, is that you build a qubit and the information just doesn’t last very long,” said Andrew Houck, leader of a federally funded national quantum research center, Princeton’s dean of engineering and co-principal investigator on the paper. “This is the next big jump forward.”
In a Nov. 5 article in the journal Nature, the Princeton team reported their new ...
People who have been treated in psychiatric care against their will are at increased risk of taking their own lives after hospital discharge. This is shown by a new study from Karolinska Institutet published in the journal The Lancet Regional Health – Europe. The results highlight a need for follow-up care after discharge.
Every year, more than 10,000 people in Sweden receive involuntary inpatient psychiatric care. This compulsory care is provided in cases of serious mental disorder where there is an urgent need for inpatient care, but the person refuses care. A new study now shows that ...
Across Asia's vast drylands, a new study reveals a critical imbalance between degradation and recovery. Researchers analyzed two decades of satellite data and developed an integrated ecohealth-neutrality framework to track how land ecosystems have changed from 2000 to 2020. The findings show that while ecohealth began improving after 2012, degradation still dominates, with about 22% of the region's land (196 million hectares) remains degraded, compared to only 13% (119 million hectares) showing recovery. This 8% “land debt” indicates the fragile balance between human activity ...
